SEC 13F Intelligence

Swiss National Bank / LLY

Swiss National Bank’s Eli Lilly & Co Position

Does Swiss National Bank own Eli Lilly & Co (LLY)? Yes — 2.36M shares worth $2.2B (+1.25% of its 13F portfolio) as of Q1 2026, up from 2.20M shares the prior filed quarter.

Position Value
$2.2B
Q1 2026
Shares
2.36M
% of Portfolio
+1.25%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $427MQ4 ’18Q1 ’19: $455MQ2 ’19: $380MQ3 ’19: $378MQ4 ’19: $426MQ4 ’19Q1 ’20: $544MQ2 ’20: $647MQ3 ’20: $576MQ4 ’20: $642MQ4 ’20Q1 ’21: $722MQ2 ’21: $762MQ3 ’21: $745MQ4 ’21: $854MQ4 ’21Q1 ’22: $1.0BQ2 ’22: $1.1BQ3 ’22: $1.1BQ4 ’22: $1.2BQ4 ’22Q1 ’23: $1.1BQ2 ’23: $1.4BQ3 ’23: $1.4BQ4 ’23: $1.5BQ4 ’23Q1 ’24: $1.9BQ2 ’24: $2.2BQ3 ’24: $2.1BQ4 ’24: $1.8BQ4 ’24Q1 ’25: $1.9BQ2 ’25: $1.9BQ3 ’25: $1.8BQ4 ’25: $2.4BQ4 ’25Q1 ’26: $2.2Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.36M$2.2B+1.25%
Q4 20252.20M$2.4B+1.41%
Q3 20252.32M$1.8B+1.03%
Q2 20252.44M$1.9B+1.14%
Q1 20252.28M$1.9B+1.33%
Q4 20242.28M$1.8B+1.17%
Q3 20242.40M$2.1B+1.38%
Q2 20242.39M$2.2B+1.49%
Q1 20242.42M$1.9B+1.32%
Q4 20232.52M$1.5B+1.08%
Q3 20232.60M$1.4B+1.09%
Q2 20232.92M$1.4B+0.93%
Q1 20233.21M$1.1B+0.75%
Q4 20223.28M$1.2B+0.86%
Q3 20223.50M$1.1B+0.81%
Q2 20223.51M$1.1B+0.77%
Q1 20223.52M$1.0B+0.57%
Q4 20213.09M$854M+0.51%
Q3 20213.22M$745M+0.47%
Q2 20213.32M$762M+0.47%
Q1 20213.87M$722M+0.48%
Q4 20203.80M$642M+0.46%
Q3 20203.89M$576M+0.45%
Q2 20203.94M$647M+0.55%
Q1 20203.92M$544M+0.58%
Q4 20193.24M$426M+0.44%
Q3 20193.38M$378M+0.40%
Q2 20193.43M$380M+0.41%
Q1 20193.51M$455M+0.50%
Q4 20183.69M$427M+0.55%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Swiss National Bank’s full portfolio or all institutional holders of LLY.